NCT00456495 2017-07-21
Effect of Ranibizumab on Malignant Conjunctival Neoplasia
The New York Eye Cancer Center
Phase 1 Completed
Clinical Trials
9 trialsNCT00680225 2017-04-12
Lucentis as an Adjuvant Therapy With TTT-ICG Based in Choroidal Melanoma
New England Retina Associates
Phase 3 Completed
NCT00765921 2016-12-02
Ranibizumab in Combination With Proton Beam Irradiation for Choroidal Melanoma
Massachusetts Eye and Ear Infirmary
Phase 1 Completed
NCT01251978 2016-10-19
Ranibizumab as Adjuvant Therapy for the Treatment of Choroidal Melanoma (Cohort 2)
New England Retina Associates
Phase 2 Completed
NCT00657202 2016-07-07
Ranibizumab for Neurofibromas Associated With Neurofibromatosis 1
Massachusetts General Hospital
Phase EARLY_PHASE1 Completed
NCT01899066 2014-05-13
Efficacy Study of Lucentis in the Treatment of Retinoblastoma
Sun Yat-sen University
Phase 2 Unknown
NCT00750399 2012-04-26
Effect of Intravitreal Ranibizumab on Radiation Retinopathy Following Plaque Brachytherapy for Choroidal Melanoma
The New York Eye Cancer Center
Phase 1 Completed
NCT00811200 2009-07-02
TORR
Leiden University Medical Center
Phase 2/3 Unknown
NCT00540930 2007-10-08
Intravitreal Ranibizumab for the Prevention of Radiation Maculopathy Following Plaque Radiotherapy
Shields, Shields and Associates
Phase 4 Unknown